Improvement in Photostability of Pantoprazole Sodium by Microencapsulation

References

1. 1.↵
   1. Shin J.,
   2. Besancon M.,
   3. Simon A.,
   4. Sachs G

   . The site of action of pantoprazole in the gastric H+/K+-ATPase. Biochim Biophys Acta 1993, 1148 (2), 223– 233.

   OpenUrlPubMedWeb of ScienceGoogle Scholar
2. 2.↵
   1. Cheer S.,
   2. Prakash A.,
   3. Faulds D.,
   4. Lamb H

   . Pantoprazole—an update of its pharmacological properties and therapeutic use in the management of acid-related disorders. Drugs 2003, 63 (1), 101– 132.

   OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
3. 3.↵
   1. Raffin R. P.,
   2. Coloméé L. M.,
   3. Guterres S. S.,
   4. Pohlmann A. R

   . Enteric controlled release pantoprazole-loaded microparticles prepared using Eudragit S100 and poly(ε-caprolactone) blend. Pharm. Dev. Technol. 2007, 12 (5), 463– 471.

   OpenUrlPubMedGoogle Scholar
4. 4.↵
   1. Raffin R. P.,
   2. Guterres S. S.,
   3. Pohlmann A. R.,
   4. Ré M. I

   . Powder characteristics of pantoprazole delivery systems produced in different spray-dryer scales. Drying Technol. 2006, 24 (1–2), 339– 348.

   OpenUrlGoogle Scholar
5. 5.↵
   1. Jyothi N. V.,
   2. Prasanna M.,
   3. Prabha S.,
   4. Seetha P. R.,
   5. Srawan G.,
   6. Sakarkar S

   . Microencapsulation techniques, factors influencing encapsulation efficiency: a review. Internet Journal of Nanotechnology 2009, 3 (1).

   Google Scholar
6. 6.↵
   1. Raffin R. P.,
   2. Jornada D. S.,
   3. Pohlmann A. R.,
   4. Guterres S. S

   . Sodium pantoprazole-loaded enteric microparticles prepared by spray drying: effect of the scale of production and process validation. Int. J. Pharm. 2006, 324 (1), 10– 18.

   OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
7. 7.↵
   1. Raffin R. P.,
   2. Colomé L. M.,
   3. Hoffmeister C. R.,
   4. Colombo P.,
   5. Rossi A.,
   6. Sonvico F.,
   7. Natalini C. C.,
   8. Pohlmann A. R.,
   9. Costa T. D.,
   10. Guterres S. S

   . Pharmacokinetics evaluation of soft agglomerates for prompt delivery of enteric pantoprazole-loaded microparticles. Eur. J. Pharm Biopharm. 2010, 74 (2), 275– 280.

   OpenUrlPubMedGoogle Scholar
8. 8.↵
   1. Tonnesen H. H

   Photostability Testing of Drug and Drug Formulations Why and How? In Photostability of Drugs and Drug Formulations, 2nd ed. Tonnesen H. H . Ed. CRC Press LLC: Boca Raton FL, 2004, pp 1–5.

   Google Scholar
9. 9.↵
   1. Tennes H. H

   1. Thorma K

   . Photodecomposition and Stabilization of Compounds in Dosage Forms. In Photostability of Drugs and Drug Formulations. Tennes H. H . Ed. CRC Press: London, 1996; pp 111–140.

   Google Scholar
10. 10.↵
    1. Glass B. D.,
    2. Novak C. S.,
    3. Brown M. E

    . The thermal and photostability of solid pharmaceuticals: a review. J. Therm. Anal. Calorim. 2004, 77 (3), 1013– 1036.

    OpenUrlGoogle Scholar
11. 11.↵
    1. Scalia S.,
    2. Tursilli R.,
    3. Sala N.,
    4. Iannuccelli V

    . Encapsulation in lipospheres of the complex between butyl methoxydibenzoylmethane and hydroxypropyl-b-cyclodextrin. Int. J. Pharm. 2006, 320 (1–2), 79– 85.

    OpenUrlPubMedGoogle Scholar
12. 12.↵
    1. Tursilli R.,
    2. Casolari A.,
    3. Iannuccelli V.,
    4. Scalia S

    . Enhancement of melatonin photostability by encapsulation in lipospheres. J. Pharm. Biomed. Anal. 2006, 40 (4), 910– 914.

    OpenUrlPubMedGoogle Scholar
13. 13.↵
    1. El-Sherif Z. A.,
    2. Mohamed A. O.,
    3. El-Bardicy M. G.,
    4. El-Tarras M. F

    . Reversed phase high performance liquid chromatographic method for the determination of lansoprazole, omeprazole and pantoprazole sodium sesquihydrate in presence of the acid-induced degradation products. Chem. Pharm. Bull. 2006, 54 (6), 814– 818.

    OpenUrlPubMedGoogle Scholar
14. 14.↵
    1. Ekpe A.,
    2. Jacobsen T

    . Effect of various salts on the stability of lansoprazole, omeprazole, and pantoprazole as determined by high-performance liquid chromatography. Drug Dev. Ind. Pharm. 1999, 25 (9), 1057– 1065.

    OpenUrlPubMedGoogle Scholar
15. 15.↵
    1. Garcia C. V.,
    2. Nudelman N. S.,
    3. Steppe M.,
    4. Schapoval E. E. S

    . Structural elucidation of rabeprazole sodium photodegradation products. J. Pharm. Biomed. Anal. 2003, 46 (1), 88– 93.

    OpenUrlGoogle Scholar
16. 16.↵
    1. Raffin R. P.,
    2. Coloméé L. M.,
    3. Scapoval E. E.,
    4. Pohlmann A. R.,
    5. Guterres S. S

    . Increasing sodium pantoprazole photostability by microencapsulation: effect of polymer and the preparation technique. Eur. J. Pharm. Biopharm., 2008, 69 (3), 1014– 1018.

    OpenUrlPubMedGoogle Scholar
17. 17.↵
    1. Raffin R. P.,
    2. Colome L. M.,
    3. Pohlmann A. R.,
    4. Guterres S. S

    . Preparation, characterization, and in vivo anti-ulcer evaluation of pantoprazole-loaded microparticles. Eur. J. Pharm. Biopharm, 2006, 63 (2), 198– 204.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
18. 18.↵
    1. D'Souza S.,
    2. DeLuca P

    . Methods to assess in vitro drug release of injectable polymeric particulate systems. Pharm. Res. 2006, 23 (3), 460– 474.

    OpenUrlPubMedGoogle Scholar